Home > Boards > US Listed > Biotechs > Genaera Corp. (GENR)

The Lomucin trial has been reduced by 60%

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile DewDiligence Member Level 
Monday, April 02, 2007 4:26:58 PM
Re: None Post # of 234 
The Lomucin trial has been reduced by 60% (from 200 patients to 80):

http://www.sec.gov/Archives/edgar/data/880431/000119312507072115/d8k.htm

It would probably make more sense to end the trial now—and thereby conserve as much cash as possible—because the whole Lomucin program is a freaking joke, IMO.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Genaera Corp. (GENR) Stock Trading Info:
Genaera Corp. GENR Stock Quote Genaera Corp. GENR Stock Charts Genaera Corp. GENR Financial
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist